Early clinical trials by Merck are showing promise for a pre-exposure prophylaxis (PrEP) implant that could last up to a year. The move could be “game-changing” for those who use PrEP to halt HIV transmission.
The results were presented at…
A PrEP implant could be potentially game-changing against HIV.